Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

10 results
Display

Clinical significance of human papillomavirus genotyping

Choi YJ, Park JS

Cervical cancer is the fourth most common cancer in women worldwide, and the human papillomavirus (HPV) is the main causative agent for its development. HPV is a heterogeneous virus, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues

Shen Y, Li Y, Ye F, Wang F, Wan X, Lu W, Xie X

Quantitative real-time RT-PCR (RT-qPCR) is being widely used in microRNA expression research. However, few reports detailed a robust identification and validation strategy for suitable reference genes for normalisation in microRNA...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic factors for patients with cervical cancer treated with concurrent chemoradiotherapy: a retrospective analysis in a Japanese cohort

Endo D, Todo Y, Okamoto K, Minobe S, Kato H, Nishiyama

OBJECTIVE: Concurrent chemoradiotherapy (CCRT) is the primary treatment for locally advanced cervical cancer. We studied prognostic factors for patients treated with CCRT. METHODS: We retrospectively reviewed records of 85 consecutive patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer

Lee J, Kim TH, Kim GE, Keum KC, Kim YB

OBJECTIVE: We aimed to assess the efficacy of neoadjuvant chemotherapy followed by surgery (NACT+S), and compared the clinical outcome with that of concurrent chemoradiotherapy (CCRT) in patients with International Federation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Major clinical research advances in gynecologic cancer in 2013

Suh DH, Kim JW, Kang S, Kim HJ, Lee KH

In 2013, 10 topics were selected for major clinical research advances in gynecologic oncology; these included three topics regarding cervical cancer, three regarding ovarian cancer, two regarding endometrial cancer, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prospective comparison of hybrid capture 2 and SPF₁₀-LiPA for carcinogenic human papillomavirus detection and risk prediction of cervical cancer: a population-based cohort study in China

Dong L, Feng RM, Zhang L, Xu XQ, Zhao XL, Wang MZ, Qiao YL, Zhao FH

OBJECTIVE: To investigate the extent of the cross-reactivity of hybrid capture 2 (HC2) assay and evaluate the potential effect of cross-reactivity on the long-term risk for cervical cancer and precancers. METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Analysis of Behavioral Stage in Pap Testing by Using Transtheoretical Model

Lee HJ, Lee SH, Jung SH, Shin HR, Oh DK

  • KMID: 1747574
  • J Prev Med Public Health.
  • 2005 Feb;38(1):82-92.
OBJECTIVE: To evaluate the relationships among sociodemographic characteristics, health behaviors, levels of pros and cons and stages of change in Pap testing for uterine cervical cancer. METHODS: A questionnaire survey...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors Associated with Cancer Screening Participation, Korea

Kwak MS, Park EC, Bang JY, Sung NY, Lee JY, Choi KS

  • KMID: 792380
  • J Prev Med Public Health.
  • 2005 Nov;38(4):473-481.
OBJECTIVES: We wanted to identify those factors associated with stomach, colon, breast and cervix cancer screening. METHODS: A population-based telephone survey was conducted for 2 weeks (the 9th-23th of July,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population

Zhao XL, Hu SY, Zhang Q, Dong L, Feng RM, Han R, Zhao FH

OBJECTIVE: To explore the genotype distribution of high-risk human papillomavirus (HR-HPV) and its attribution to different grades of cervical lesions in rural China, which will contribute to type-specific HPV screening...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study

Sun P, Song Y, Ruan G, Mao X, Kang Y, Dong B, Lin F

OBJECTIVE: To determine the clinical significance of the polymerase chain reaction (PCR)-reverse dot blot (RDB) human papillomavirus (HPV) genotyping assay in cervical cancer screening. METHODS: A total of 10,442 women attending...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr